Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate update and reported financial results for the first quarter ended March 31, 2025.

Novel RBM39 molecular glue achieves complete tumor regression in mechanism-based Ewing sarcoma models; IND filing expected ...

Equillium, Inc. , a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today ...

The Food and Drug Administration Agency (FDA) has updated the regulatory status of Marie®, Leo Cancer Care's upright particle ...

Mecbotamab vedotin (Mec-V; CAB-AXL-ADC) continues to demonstrate exceptional overall survival (OS) with a 2-year landmark ...

Imagine if agricultural and food byproducts could be transformed into an effective and holistic feed for livestock while also ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

Six posters presented at the American Association for Cancer Research (AACR) annual meetingAppointment of Dr. Sabeen Mekan as Senior Vice President, Clinical DevelopmentReported $321.6 million in cash ...

Researchers show how mice fed a Western-style diet are not able to rebuild a 'healthy,' diverse gut microbiome following antibiotic treatment. These mice were also more susceptible to infection by ...

A major population study reveals that diets high in ultra-processed foods are tied to poorer mental health, and uncovers biological markers that help explain the link. Study: Associations of Ultra ...

Findings highlight PL9654 and PL9655's potential to treat diabetic retinopathy through inflammation resolution, vascular stabilization, and neuroprotection PL9654 ...

The government is now touting biotechnology as South Korea's next ... In 1998, the government administratively reorganized the South Korean Food and Drug Administration (KFDA; Seoul).